These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8927950

  • 1. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
    Huber S, Spycher M, Lechner-Scott J, Bellaiche Y, Steck AJ, Kappos L.
    Schweiz Med Wochenschr; 1996 Aug 31; 126(35):1475-81. PubMed ID: 8927950
    [Abstract] [Full Text] [Related]

  • 2. [Interferon-beta 1B in the treatment of remittent-recurrent multiple sclerosis. Clinical experience of the Valencia group. Multiple sclerosis study group of the city of Valencia].
    Rev Neurol; 1997 Dec 31; 25(148):1876-9. PubMed ID: 9528021
    [Abstract] [Full Text] [Related]

  • 3. [Interferon therapy of multiple sclerosis].
    Jensen D.
    Tidsskr Nor Laegeforen; 1999 Sep 10; 119(21):3142-5. PubMed ID: 10522481
    [Abstract] [Full Text] [Related]

  • 4. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.
    Clin Ther; 2008 Jun 10; 30(6):1102-12. PubMed ID: 18640466
    [Abstract] [Full Text] [Related]

  • 5. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug 10; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract] [Full Text] [Related]

  • 6. Interferon beta-1b and secondary progressive multiple sclerosis: licence extension. Useful, but further assessment required.
    Prescrire Int; 2000 Aug 10; 9(48):110-1. PubMed ID: 11067719
    [Abstract] [Full Text] [Related]

  • 7. [Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b].
    Río J, Marzo ME, Tintoré M, Borrás C, Montalbán X.
    Neurologia; 1998 Nov 10; 13(9):422-6. PubMed ID: 9883016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
    Prescrire Int; 1998 Oct 10; 7(37):142-3. PubMed ID: 10915418
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M, Hommes OR, Hughes RA, Paty DW, Abdul-Ahad AK.
    Mult Scler; 1995 Oct 10; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.
    Fernández O, Guerrero M, Mayorga C, Muñoz L, Leán A, Luque G, Hervás M, Fernández V, Capdevila A, de Ramón E.
    J Neurol; 2002 Aug 10; 249(8):1058-62. PubMed ID: 12195454
    [Abstract] [Full Text] [Related]

  • 19. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G, Horowski R.
    Med Klin (Munich); 2001 Sep 15; 96 Suppl 1():3-9. PubMed ID: 11603113
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.